135 related articles for article (PubMed ID: 11312924)
1. Angular methoxy-substituted furo- and pyranoquinolinones as blockers of the voltage-gated potassium channel Kv1.3.
Butenschön I; Möller K; Hänsel W
J Med Chem; 2001 Apr; 44(8):1249-56. PubMed ID: 11312924
[TBL] [Abstract][Full Text] [Related]
2. Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity.
Baell JB; Gable RW; Harvey AJ; Toovey N; Herzog T; Hänsel W; Wulff H
J Med Chem; 2004 Apr; 47(9):2326-36. PubMed ID: 15084131
[TBL] [Abstract][Full Text] [Related]
3. Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels.
Koo GC; Blake JT; Shah K; Staruch MJ; Dumont F; Wunderler D; Sanchez M; McManus OB; Sirotina-Meisher A; Fischer P; Boltz RC; Goetz MA; Baker R; Bao J; Kayser F; Rupprecht KM; Parsons WH; Tong XC; Ita IE; Pivnichny J; Vincent S; Cunningham P; Hora D; Feeney W; Kaczorowski G
Cell Immunol; 1999 Nov; 197(2):99-107. PubMed ID: 10607427
[TBL] [Abstract][Full Text] [Related]
4. 3-Alkyl- and 3-aryl-7H-furo[3,2-g]chromen-7-ones as blockers of the voltage-gated potassium channel Kv1.3.
Wernekenschnieder A; Körner P; Hänsel W
Pharmazie; 2004 Apr; 59(4):319-20. PubMed ID: 15125582
[TBL] [Abstract][Full Text] [Related]
5. A new class of blockers of the voltage-gated potassium channel Kv1.3 via modification of the 4- or 7-position of khellinone.
Harvey AJ; Baell JB; Toovey N; Homerick D; Wulff H
J Med Chem; 2006 Feb; 49(4):1433-41. PubMed ID: 16480279
[TBL] [Abstract][Full Text] [Related]
6. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
[TBL] [Abstract][Full Text] [Related]
7. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.
Beeton C; Barbaria J; Giraud P; Devaux J; Benoliel AM; Gola M; Sabatier JM; Bernard D; Crest M; Béraud E
J Immunol; 2001 Jan; 166(2):936-44. PubMed ID: 11145670
[TBL] [Abstract][Full Text] [Related]
8. Candelalides A-C: novel diterpenoid pyrones from fermentations of Sesquicillium candelabrum as blockers of the voltage-gated potassium channel Kv1.3.
Singh SB; Zink DL; Dombrowski AW; Dezeny G; Bills GF; Felix JP; Slaughter RS; Goetz MA
Org Lett; 2001 Jan; 3(2):247-50. PubMed ID: 11430046
[TBL] [Abstract][Full Text] [Related]
9. Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant properties.
Schmalhofer WA; Bao J; McManus OB; Green B; Matyskiela M; Wunderler D; Bugianesi RM; Felix JP; Hanner M; Linde-Arias AR; Ponte CG; Velasco L; Koo G; Staruch MJ; Miao S; Parsons WH; Rupprecht K; Slaughter RS; Kaczorowski GJ; Garcia ML
Biochemistry; 2002 Jun; 41(24):7781-94. PubMed ID: 12056910
[TBL] [Abstract][Full Text] [Related]
10. Benzamide derivatives as blockers of Kv1.3 ion channel.
Miao S; Bao J; Garcia ML; Goulet JL; Hong XJ; Kaczorowski GJ; Kayser F; Koo GC; Kotliar A; Schmalhofer WA; Shah K; Sinclair PJ; Slaughter RS; Springer MS; Staruch MJ; Tsou NN; Wong F; Parsons WH; Rupprecht KM
Bioorg Med Chem Lett; 2003 Mar; 13(6):1161-4. PubMed ID: 12643934
[TBL] [Abstract][Full Text] [Related]
11. Identification, synthesis, and activity of novel blockers of the voltage-gated potassium channel Kv1.5.
Peukert S; Brendel J; Pirard B; Brüggemann A; Below P; Kleemann HW; Hemmerle H; Schmidt W
J Med Chem; 2003 Feb; 46(4):486-98. PubMed ID: 12570371
[TBL] [Abstract][Full Text] [Related]
12. K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression.
Panyi G; Possani LD; Rodríguez de la Vega RC; Gáspár R; Varga Z
Curr Pharm Des; 2006; 12(18):2199-220. PubMed ID: 16787250
[TBL] [Abstract][Full Text] [Related]
13. Potent Kv1.3 inhibitors from correolide-modification of the C18 position.
Bao J; Miao S; Kayser F; Kotliar AJ; Baker RK; Doss GA; Felix JP; Bugianesi RM; Slaughter RS; Kaczorowski GJ; Garcia ML; Ha SN; Castonguay L; Koo GC; Shah K; Springer MS; Staruch MJ; Parsons WH; Rupprecht KM
Bioorg Med Chem Lett; 2005 Jan; 15(2):447-51. PubMed ID: 15603971
[TBL] [Abstract][Full Text] [Related]
14. Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3.
Rodrigues AR; Arantes EC; Monje F; Stühmer W; Varanda WA
Br J Pharmacol; 2003 Jul; 139(6):1180-6. PubMed ID: 12871837
[TBL] [Abstract][Full Text] [Related]
15. Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation.
Fraser SP; Grimes JA; Diss JK; Stewart D; Dolly JO; Djamgoz MB
Pflugers Arch; 2003 Aug; 446(5):559-71. PubMed ID: 12838421
[TBL] [Abstract][Full Text] [Related]
16. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
Vennekamp J; Wulff H; Beeton C; Calabresi PA; Grissmer S; Hänsel W; Chandy KG
Mol Pharmacol; 2004 Jun; 65(6):1364-74. PubMed ID: 15155830
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive effects of a Kv1.3 inhibitor.
Shah K; Tom Blake J; Huang C; Fischer P; Koo GC
Cell Immunol; 2003 Feb; 221(2):100-6. PubMed ID: 12747950
[TBL] [Abstract][Full Text] [Related]
18. The voltage- and time-dependent blocking effect of trifluoperazine on T lymphocyte Kv1.3 channels.
Teisseyre A; Michalak K
Biochem Pharmacol; 2003 Feb; 65(4):551-61. PubMed ID: 12566082
[TBL] [Abstract][Full Text] [Related]
19. Stable expression of human Kv1.3 potassium channels resets the resting membrane potential of cultured mammalian cells.
Defarias FP; Stevens SP; Leonard RJ
Recept Channels; 1995; 3(4):273-81. PubMed ID: 8834000
[TBL] [Abstract][Full Text] [Related]
20. Voltage-gated K+ channels in rat small cerebral arteries: molecular identity of the functional channels.
Albarwani S; Nemetz LT; Madden JA; Tobin AA; England SK; Pratt PF; Rusch NJ
J Physiol; 2003 Sep; 551(Pt 3):751-63. PubMed ID: 12815189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
